Apolipoprotein A-I Mimetics for Treatment of the Residual Risk of Cardiovascular Disease
CardioMetabolic Syndrome Journal · 2021
DOI: 10.51789/cmsj.2021.1.e13 ↗Kurz gefasst
Fachartikel in der Zeitschrift CardioMetabolic Syndrome Journal, 2021. Verfasst von Shin-ichiro Miura und 6 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Fukuoka University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- Fukuoka University
Zitieren
APA
Miura, S., Suematsu, Y., Imaizumi, S., Yahiro, E., Kuwano, T., Uehara, Y., & Saku, K. (2021). Apolipoprotein A-I Mimetics for Treatment of the Residual Risk of Cardiovascular Disease. CardioMetabolic Syndrome Journal. https://doi.org/10.51789/cmsj.2021.1.e13
Vancouver
Miura S, Suematsu Y, Imaizumi S, Yahiro E, Kuwano T, Uehara Y, et al. Apolipoprotein A-I Mimetics for Treatment of the Residual Risk of Cardiovascular Disease. CardioMetabolic Syndrome Journal. 2021. doi:10.51789/cmsj.2021.1.e13
BibTeX
@article{Miura2021,
author = {Miura, Shin-ichiro and Suematsu, Yasunori and Imaizumi, Satoshi and Yahiro, Eiji and Kuwano, Takashi and Uehara, Yoshinari and Saku, Keijiro},
title = {Apolipoprotein A-I Mimetics for Treatment of the Residual Risk of Cardiovascular Disease},
journal = {CardioMetabolic Syndrome Journal},
year = {2021},
doi = {10.51789/cmsj.2021.1.e13}
}
EUVIMED